KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Biocryst Pharmaceuticals (BCRX) over the last 16 years, with Dec 2024 value amounting to -$2.0 million.

  • Biocryst Pharmaceuticals' Other Working Capital Changes fell 107.59% to -$403,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $1.2 million, marking a year-over-year decrease of 72.93%. This contributed to the annual value of -$2.0 million for FY2024, which is 128.72% down from last year.
  • As of FY2024, Biocryst Pharmaceuticals' Other Working Capital Changes stood at -$2.0 million, which was down 128.72% from $6.8 million recorded in FY2023.
  • In the past 5 years, Biocryst Pharmaceuticals' Other Working Capital Changes registered a high of $7.2 million during FY2021, and its lowest value of -$2.0 million during FY2024.
  • Its 3-year average for Other Working Capital Changes is $2.5 million, with a median of $2.6 million in 2022.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first spiked by 234.35% in 2021, then tumbled by 128.72% in 2024.
  • Biocryst Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $2.1 million in 2020, then soared by 234.35% to $7.2 million in 2021, then plummeted by 63.90% to $2.6 million in 2022, then soared by 164.03% to $6.8 million in 2023, then tumbled by 128.72% to -$2.0 million in 2024.